TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

British Journal of Cancer, Published online: 20 December 2019; doi:10.1038/s41416-019-0688-yTAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

http://feeds.nature.com/~r/bjc/rss/current/~3/i7nSkbENcPA/s41416-019-0688-y

Source: British Journal of Cancer - December 19, 2019 Category: Cancer & Oncology Authors: Yurina Saito Tsuyoshi Takahashi Yuuki Obata Toshirou Nishida Shuichi Ohkubo Fumio Nakagawa Satoshi Serada Minoru Fujimoto Tomoharu Ohkawara Takahiko Nishigaki Takahito Sugase Masahiro Koh Tomo Ishida Koji Tanaka Yasuhiro Miyazaki Tomoki Makino Yukinori Ku Source Type: research